US Approves Drug to Slow Early Effects of Alzheimer’s Disease

US Approves Drug to Slow Early Effects of Alzheimer’s Disease

U.S. officials gave full approval last week to Leqembi, a drug that slows Alzheimer’s disease, which harms the brain. It is approved for use with patients in the early stages of the disease.

Source : https://learningenglish.voanews.com/a/us-approves-drug-to-slow-early-effects-of-alzheimer-s-disease-/7171589.html

Pour accéder à votre E-Learning, connectez-vous en cliquant sur le bouton correspondant à votre centre de formation :

Connexion Clermont-Ferrand Connexion Orléans Connexion Lyon Connexion Paris